Revisiting long-standing biological questions through evolving technologies.

Hepatic arterial infusion chemotherapy-based triplet conversion therapy for hepatocellular carcinoma with portal vein tumor thrombus: Evidence, patient selection, and surgical endpoints.

Stem cell-derived extracellular vesicles for rare diseases: A clinical‑bottleneck‑to‑mechanism framework for translation.

PRXL2B facilitates the progression of hepatocellular carcinoma and the therapeutic efficacy of oncolytic adenovirus H101 through the PI3K/AKT/PD-L1 axis.

Management of dynamic therapeutic opportunity in hepatocellular carcinoma: Preserving liver function and enabling treatment transitions.

Gene expression profiling of the L4-stage nematode Caenorhabditis elegans following ethanol exposure.

Revisiting long-standing biological questions through evolving technologies.

Hepatic arterial infusion chemotherapy-based triplet conversion therapy for hepatocellular carcinoma with portal vein tumor thrombus: Evidence, patient selection, and surgical endpoints.

Stem cell-derived extracellular vesicles for rare diseases: A clinical‑bottleneck‑to‑mechanism framework for translation.

PRXL2B facilitates the progression of hepatocellular carcinoma and the therapeutic efficacy of oncolytic adenovirus H101 through the PI3K/AKT/PD-L1 axis.

Management of dynamic therapeutic opportunity in hepatocellular carcinoma: Preserving liver function and enabling treatment transitions.

Gene expression profiling of the L4-stage nematode Caenorhabditis elegans following ethanol exposure.